NovoCure (NVCR) Operating Income (QoQ) (2014 - 2026)
NovoCure (NVCR) Operating Income (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.33% |
| Mar 31, 2026 | -66.91% |
| Dec 31, 2025 | -12.14% |
| Sep 30, 2025 | 8.86% |
| Jun 30, 2025 | -4.37% |
| Mar 31, 2025 | 40.19% |
| Dec 31, 2024 | -97.26% |
| Sep 30, 2024 | 4.43% |
| Jun 30, 2024 | 19.12% |
| Mar 31, 2024 | 19.72% |
| Dec 31, 2023 | 11.21% |
| Sep 30, 2023 | 7.05% |
| Jun 30, 2023 | -4.00% |
| Mar 31, 2023 | -40.19% |
| Dec 31, 2022 | -74.63% |
| Sep 30, 2022 | -16.49% |
| Jun 30, 2022 | -2,521.34% |
| Mar 31, 2022 | 96.56% |
| Dec 31, 2021 | -173.60% |
| Sep 30, 2021 | 30.44% |